Details on past award winners are attached, including the 2025 awardees Drs
This structural preference provides a mechanistic basis for improved intestinal bioavailability of DHA-rich lipids
Differences in mammalian target of rapamycin gene expression in the peripheral blood and articular cartilages of osteoarthritic patients and disease activity
When a Patient Should Discuss Heart Risk Before GLP-1 Therapy Patients should discuss cardiovascular risk before starting GLP-1 therapy if they have a history of heart attack, stroke, coronary artery disease, stents, heart failure, high blood pressure, high cholesterol, diabetes, kidney disease, sleep apnea, fatty liver disease, or a strong family history of heart disease
The 96365 CPT code refers to the first hour of an intravenous infusion for therapy, prophylaxis, or diagnostic purposes
What is IGF-1 DES and how does it compare to LR3